Contract Service Directory

Hiray Pharma Solutions





Company Headquarters

15 TW Alexander Drive
Suite 415
Durham, NC 27703
United States

Contract Service Directory

    Related Content

    • MHI Introduces Small-batch Blister Machine

      MHI Introduces Small-batch Blister Machine

      Designed as a reliable, cost-effective solution for development stages, stability testing and initial small-batch production.
      02.02.23

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

      Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

      Novel AAV capsid Anc80 enables efficient gene transfer.
      02.01.23

    • Breaking News | Facilities | Industry News
      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Milestone for the development of Lonza’s first large-scale drug product manufacturing facility based in Stein.
      02.01.23


    • Breaking News | cGMP Manufacture | Industry News
      EUROAPI Reports Progressive Restart of Prostaglandin Production

      EUROAPI Reports Progressive Restart of Prostaglandin Production

      Majority of production at the Budapest site expected to be back online by mid-April 2023.
      02.01.23

    • Breaking News | Promotions & Moves
      Exothera Names Darren Leva as Chief Business Officer

      Exothera Names Darren Leva as Chief Business Officer

      Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies.
      02.01.23

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      New CDMO Vector BioMed Launches Operations

      New CDMO Vector BioMed Launches Operations

      The biomanufacturing company’s mission is to provide access to high-quality lentiviral vectors and address the vector supply bottleneck.
      02.01.23


    • Breaking News | Drug Development | Facilities | Industry News
      Mikart Invests in New Liquids and Suspensions Suite

      Mikart Invests in New Liquids and Suspensions Suite

      Enhances liquid oral drug product development and manufacturing capabilities of complex formulations.
      02.01.23

    • Breaking News | Financial Reports
      Pfizer Revenues Soar to Record-Breaking $100B in 2022

      Pfizer Revenues Soar to Record-Breaking $100B in 2022

      Comirnaty and Paxlovid rake in $56.7 billion in 2022 while sales of these COVID products are expected to decline as much as 60% in 2023.
      01.31.23

    • Breaking News | Facilities | Industry News
      Lilly to Invest $450M at Manufacturing Site in Research Triangle Park

      Lilly to Invest $450M at Manufacturing Site in Research Triangle Park

      Expansion includes additional parenteral filling, device assembly and packaging capacity to support an increased demand for Lilly's incretin products.
      01.30.23